Home > Healthcare > Medical Devices > Therapeutic Devices > Nephrostomy Devices Market

Nephrostomy Devices Market Analysis

Report ID: GMI4325
Published Date: May 2023
Report Format: PDF

Download Free Sample

Nephrostomy Devices Market Analysis

Global Nephrostomy Devices Market Size, By Product,

Based on product, the market is segmented as guidewires, drainage tubes, nephrostomy catheters, sheath dilators and others. The guidewires dominated the nephrostomy devices market in 2022 accounting for more than 32% of the total industry share. This high market share is owing to several benefits offered by guidewires in the management of kidney disorders. These devices guide the placement in the kidney and reduce the risk of complications such as bleeding or injury to surrounding organs. Additionally, these devices help reduce the trauma to surrounding tissues, minimize pain and discomfort and help in improving the safety of the procedure.

Global Nephrostomy Devices Market Share, By End-use,

Learn more about the key segments shaping this market

Download Free Sample

Based on end-use, the nephrostomy devices market is segmented as hospitals, clinics, ambulatory surgical centers and others. The hospital segment held the highest industry share in 2022 and is projected to grow at 8.2% CAGR from 2023-2032. This high market share is owing to the availability of advanced treatments for several kidney diseases and technologically advanced urinary catheters to assist a wide customer base. Enhanced operability and accessibility to comprehensive range of treatments incorporating nephrostomy procedures is expected to drive the market growth. Increasing admissions with chronic kidney disorders due to passive lifestyle and increasing instances of hospitalizations with a robust healthcare system is expected to boost the industry expansion. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of these disorders will boost patient visits to hospitals.

North America Nephrostomy Devices Market Size

Looking for region specific data?

Download Free Sample

U.S. nephrostomy devices market is predicted to reach around USD 863 million by 2032. This market share is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of pre nephrostomy devices for diagnosis and treatment of kidney ailments among others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for nephrostomy devices was worth around USD 1.1 billion in 2022 and is projected to surpass the valuation of around USD 2.4 billion by 2032 attributed to the high prevalence of kidney disorders, coupled with rising demand for minimally invasive surgeries.

The guidewires segment held over 32% revenue share and dominated the nephrostomy devices industry in 2022. Several benefits offered by guidewires in the management of kidney disorders are fueling product usage.

U.S. market for nephrostomy devices is projected to amass around USD 863 million by the end of 2032 driven by the presence of key market players and an increase in the number of chronic diseases.

Angiodynamics, Argon Medical Devices Inc, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Medical, Envaste Ltd., Meditech, Devices Pvt. Ltd., Olympus Corporation, ROCAMED, Teleflex, Inc., and Uresil LLC., among others.